Inflammatory biomarkers and motoric cognitive risk syndrome: Multicohort survey

Justina L Groeger1, Emmeline Ayers2, Nir Barzilai3,4

  • 1Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States.

Abstract

Insights

Inflammation, indicated by interleukin-6 (IL-6) and C-reactive protein (CRP), is linked to Motoric Cognitive Risk (MCR) syndrome in older adults. This association between inflammatory biomarkers and MCR varies with the presence of vascular disease.

Area of Science:

  • Gerontology
  • Neuroscience
  • Immunology

Background:

  • Motoric Cognitive Risk (MCR) syndrome is a pre-dementia condition characterized by slow gait and cognitive complaints.
  • Inflammation is hypothesized to play a role in the development of MCR syndrome.

Purpose of the Study:

  • To investigate the association between inflammatory biomarkers, specifically interleukin-6 (IL-6) and C-reactive protein (CRP), and the prevalence of MCR syndrome in older adults.

Main Methods:

  • A meta-analysis was conducted using data from 3,101 older adults across five cohorts.
  • Logistic regression models were employed to assess the association between IL-6 and CRP levels and MCR.
  • Analyses were adjusted for potential confounders including age, sex, education, depressive symptoms, body mass index, and vascular diseases.

Main Results:

  • A pooled meta-analysis revealed a significant association between the highest tertiles of IL-6 and CRP and MCR (aOR 1.57 and 1.65, respectively).
  • Associations varied across cohorts, with significant links observed in three out of five studies.
  • Higher CRP levels were associated with MCR in individuals with and without vascular disease, depending on the cohort.

Conclusions:

  • Elevated levels of IL-6 and CRP are associated with Motoric Cognitive Risk syndrome in older adults.
  • The relationship between these inflammatory biomarkers and MCR is influenced by the presence or absence of vascular disease.

Related Concept Videos